FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Marlborough Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amsacrine 75mg/1.5ml solution for infusion ampoules and diluent VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for injection vials and diluent (Goldshield Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsacrine 75mg/1.5ml solution for injection ampoules and diluent 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for infusion ampoules and diluent (NordMedica A/S) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for injection vials and diluent (Goldshield Healthcare Ltd) 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Amsidine 75mg/1.5ml solution for infusion ampoules and diluent (NordMedica A/S) 6 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Meningococcal C conjugate vaccine suspension for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Meningitec vaccine suspension for injection 0.5ml pre-filled syringes (Nuron Biotech B.V.) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 50 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 125mg/5ml oral suspension 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 125mg/5ml oral suspension (Drug Tariff Special Order) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) 50 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules (Lamberts Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
L-Arginine 500mg capsules (G & G Food Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 30 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Quest L-Arginine 500mg capsules (Quest Vitamins Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules (Lamberts Healthcare Ltd) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Quest L-Arginine 500mg capsules (Quest Vitamins Ltd) 30 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
L-Arginine 500mg capsules (G & G Food Supplies Ltd) 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Actavis UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Actavis UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Mawdsley-Brooks & Company Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Actavis UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Actavis UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 50micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 75micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 100micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Alliance Healthcare (Distribution) Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Alliance Healthcare (Distribution) Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 50micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 75micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mylafent 100micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets (Morningside Healthcare Ltd) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (A A H Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (J M Loveridge Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Thornton & Ross Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Unichem Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Thornton & Ross Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 5cm x 7.5cm (Charles S. Bullen Stomacare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 7.5cm x 10cm (Charles S. Bullen Stomacare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 10cm x 18cm (Charles S. Bullen Stomacare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sarstedt safety lancets 1.8mm/21gauge (Sarstedt Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use 1.8mm/21gauge 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 10cm x 18cm 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 5cm x 7.5cm (Charles S. Bullen Stomacare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 5cm x 7.5cm (Charles S. Bullen Stomacare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 7.5cm x 10cm (Charles S. Bullen Stomacare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 7.5cm x 10cm (Charles S. Bullen Stomacare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 10cm x 18cm (Charles S. Bullen Stomacare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Spycra Protect dressing 10cm x 18cm (Charles S. Bullen Stomacare Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sarstedt safety lancets 1.8mm/21gauge (Sarstedt Ltd) 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Unichem Plc) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (J M Loveridge Plc) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Thornton & Ross Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (A A H Pharmaceuticals Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets (A A H Pharmaceuticals Ltd) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (A A H Pharmaceuticals Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (A A H Pharmaceuticals Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 58 of 86 Next End

This concept is not in any reference sets

Back to Start